Prediction of Vesicouterine Adhesions by Transvaginal Sonographic Sliding Sign Technique: a Validation Study

Sponsor
Amsterdam UMC, location VUmc (Other)
Overall Status
Completed
CT.gov ID
NCT05862155
Collaborator
(none)
132
1
36.6
3.6

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the predictive value of the real-time dynamic TVS sliding sign for vesicouterine pouch adhesions in women and to test the inter- and intraobserver agreement of this new technique.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The investigators will conduct a prospective observational double-blind cohort study of patients who will have laparoscopic abdominopelvic surgery between January 2020 and December 2022 in the Amsterdam UMC. All women will be examined by TVE ultrasounds prior to surgery. The investigators will evaluate the predictive value of the real-time dynamic TVS sliding sign for vesicouterine pouch adhesions in women and test the inter- and intraobserver agreement of this technique.

    All real-time dynamic transvaginal ultrasounds will be performed as followed: By mild pressure with the vaginal probe in the anterior vagina and palpation on the fundus with the free hand, the uterus will be pushed away from the bladder. The sliding-sign will be considered to be positive when the anterior wall glided freely in relation tot the bladder, one against the other. The sliding-sign was negative when the bladder is fixated tot the uterus for more than 1 cm from the vesico-vaginal fold. Or when the distance between the vesico-vaginal fold and the vesico-uterine fold is > 1 cm.

    Two experienced gynaecologists and one resident in gynecology and obstetrics will evaluate the ultrasounds on the presence of the sliding sign independent from each other and without any knowledge of the individual patient and laparoscopic footage. All ultrasounds will be coded, so the assessors are blinded for the patients demographics and surgical history in order to interpret the sliding sign objectively.

    The recorded laparoscopic videoclips will be evaluated by one of the researchers without any knowledge of the individual patient, surgical history and ultrasounds. Therefore the laparoscopic footage will be coded. To prevent bias the assessor will be blinded to the results of the ultrasound sliding sign assessments. Adhesions between uterus and bladder, abdominal fascia and omentum are scored according the classification of Tulandi. An adhesion score of 0 will be classified as no adhesions and an adhesion score of >16 as a 'frozen bladder'.

    The obtained data will be analyzed to determine the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the sliding sign to predict the presence of absence of adhesions between the bladder and uterus. Fisher's exact test will be used to calculate the p-value for prediction of adhesions using the sliding sign technique. A P < 0.05 will be considered statistically significant. Interobserver variability will be assesed between two experienced gynecologists and between one experienced gynecologist and the resident. To assess the intraobserver variability one of the experienced gynecologists will reevaluated the same ultrasounds 2 months after the first ultrasound evaluation.

    The investigators will try to obtain 100 inclusions based on previous studies who studied the role of the abdominal sonographic sliding sign in predicting intra-abdominal adhesions in pregnant women undergoing repeat cesarean section. All women have signed an informed consent.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    132 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prediction of Vesicouterine Adhesions by the Real-time Dynamic Transvaginal Sonographic Sliding Sign Technique: a Validation Study
    Actual Study Start Date :
    Jan 27, 2020
    Actual Primary Completion Date :
    Jan 19, 2022
    Actual Study Completion Date :
    Feb 13, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Transvaginal sonographic sliding sign [Preoperative]

      Real-time dynamic transvaginal sonographic sliding sign (positive or negative sign)

    Secondary Outcome Measures

    1. Adhesion score [Intraoperative recording of laparoscopic footage with postoperative assessment of the adhesion score based on this video within 2 years]

      Adjusted classification of adhesions between uterus and bladder, abdominal fascia and omentum during laparoscopy. Total adhesion score of 0 = no adhesions. Total adhesion score of >16 = 'Frozen Bladder'.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Women > 18 years old

    • Laparoscopic abdominopelvic surgery with available video footage in Clinical Assistent

    • Recorded real-time dynamic transvaginal ultrasound with the sliding sign technique

    • Signed informed consent

    Exclusion Criteria:
    • Insufficient quality of the ultrasound

    • Unclear laparoscopic videoclip to determine the presence of adhesions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Amsterdam UMC, location AMC Amsterdam Noord-Holland Netherlands 1105 AZ

    Sponsors and Collaborators

    • Amsterdam UMC, location VUmc

    Investigators

    • Principal Investigator: Judith Huirne, Prof. Dr., Amsterdam UMC, location VUmc

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    J.A.F. Huirne, Prof. Dr. J.A.F. Huirne, Amsterdam UMC, location VUmc
    ClinicalTrials.gov Identifier:
    NCT05862155
    Other Study ID Numbers:
    • Sliding Bladder
    First Posted:
    May 17, 2023
    Last Update Posted:
    May 17, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by J.A.F. Huirne, Prof. Dr. J.A.F. Huirne, Amsterdam UMC, location VUmc
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 17, 2023